Shares of CONMED Corporation (NYSE:CNMD – Get Free Report) reached a new 52-week low during trading on Thursday . Zacks: CONMED Stock Up Post Q4 EarningsQ4 results: CONMED reported a quarter with revenue up ~7.9% year-over-year and an adjusted EPS and gross-margin beat; management cited surgical/orthopedic strength and international growth as drivers. Positive Sentiment: Analyst reaction: Wells Fargo raised its price target to $42 (equal weight), signaling some analyst support for the rebound potential. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of CONMED in a research report on Wednesday, January 21st. CONMED Stock Down 6.4%The stock has a market capitalization of $1.12 billion, a price-to-earnings ratio of 17.68, a P/E/G ratio of 1.78 and a beta of 0.96.